Charles Cohen: Why Women Wait Years Longer for a Bleeding Disorder Diagnosis
Charles Cohen, CEO at Mooncup Ltd, shared a post on LinkedIn about a recent article by Luuk J J Scheres et al., published in The Lancet Haematology, adding:
“If a man walks into a clinic with an unexplained bleeding problem, he’s typically diagnosed within about 2 years. If a woman does, it takes 14 to 16!
That figure comes from the Commission on Global Female Health and Haematology, published in The Lancet Haematology this July and presented at the International Society on Thrombosis and Haemostasis Congress in Paris, led by Dr Bethany Samuelson Bannow.
It’s the largest attempt yet to map how badly the blood side of women’s health has been neglected, and heavy periods sit right at the centre of it.
Heavy menstrual bleeding affects up to one in three women, and is often the very first sign of an inherited bleeding disorder.
That sign gets missed for years, sometimes decades.
Women remain underrepresented in the clinical trials meant to catch conditions like this earlier.
We have customers reaching out to us all the time about heavy periods and unusual bleeding, we direct them towards medical support but this does beg the question of if they are just being ignored at this stage.
One of the great things about menstrual cups is it is easy to measure blood and fluid loss, well much easier than absorbent products e.g. pads.
If you believe you have heavy periods it might be worth giving a cup a go and measuring the fluid loss over your period so that you can take this to your GP without being asked how many pads you have gone through in the last 24 hours which is extremely unreliable.
It will not provide a diagnosis, but it will give you data instead of a feeling, which is a small, concrete place to start.
Activate to view larger image, ”
Title: Reducing mortality, improving outcomes, and establishing equity for women with classical haematological disease: a Lancet Haematology Commission
Authors: Luuk J J Scheres, Angela Weyand, Maureen K Baldwin, Jecko Thachil, Maha Othman, Saskia Middeldorp, Maureen Achebe, Rezan Abdul-Kadir, Fionnuala Ní Áinle, Godwin Akaba, Imo Akpan, Homa Ahmadzia, Omolade A Awodu, Marc Blondon, Kochawan Boonyawat, Munira Borhany, Patricia Casais, Briony Cutts, Veronica Flood, Anat Gafter-Gvili, Patricia Homan, Emily Hoppes, Chandani Kharel, Claudia Khayat, Michelle Lavin, Kinga Malinowski, Kristen Matteson, Jackie Maybin, Lauren Merz, Helen Okoye, Alexandra Robledo, Leslie Skeith, Marni Sommer, Tonye Wokoma, Tahira Zafar, Bethany Samuelson Bannow

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series